DrugsControl Media Services

News Detail

US FDA expands approval of first gene therapy for rare form of muscular dystrophy (23-06-2024)

Maryland, 23 June 2024: The U.S. Food and Drug Administration has given the green light for the first gene therapy that treats a rare form of muscular dystrophy to be used in most people who have the disease and a certain genetic mutation.


Last year, the dr......
View Details

Source : ABC 7
FDA gene therapy muscular dystrophy mmnd Duchenne Muscular Dystrophy

Related News